The Zacks Industry Rank assigns a rating to each of the 265 industries based on their average Zacks Rank. An Industry with a larger percentage of Zacks Rank #1s (Strong Buy) and #2s (Buy) will have a better Zacks Industry Rank than one with a larger percentage of Zacks Rank #4s (Sell) and #5s (Strong Sell).
Finding the best industries is often the key to success in investing. Our research shows that the industries ranked in the top half outperform those in the bottom half by a factor of two to one, so putting your money to work in the best industries gives you a big advantage.
One space that should be on your radar right now is the generic drug industry. The space has moved up 48 Zacks Industry Ranks in the last week. Stocks within the gold mining sector sit in the top 18% of all 265 industries ranked on the Zacks Industry Rank.
Right now, generic drug pharmaceutical companies are ranked as the 47th best industry out of the 265 industries covered by Zacks. In the last week, the industry has seen its average Zacks Rank improve, and it has gone from an average Zacks Rank of 2.96 to a rank of 2.75.
Best of the Group
There are several promising choices in this industry right now, such as Amphastar Pharmaceuticals (AMPH - Free Report) , Doctor Reddy’s (RDY - Free Report) , and Mylan NV , all of which are a Zacks Rank #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The Zacks Industry Rank assigns a rating to each of the 265 industries based on their average Zacks Rank. An Industry with a larger percentage of Zacks Rank #1s (Strong Buy) and #2s (Buy) will have a better Zacks Industry Rank than one with a larger percentage of Zacks Rank #4s (Sell) and #5s (Strong Sell).
Finding the best industries is often the key to success in investing. Our research shows that the industries ranked in the top half outperform those in the bottom half by a factor of two to one, so putting your money to work in the best industries gives you a big advantage.
One space that should be on your radar right now is the generic drug industry. The space has moved up 48 Zacks Industry Ranks in the last week. Stocks within the gold mining sector sit in the top 18% of all 265 industries ranked on the Zacks Industry Rank.
Right now, generic drug pharmaceutical companies are ranked as the 47th best industry out of the 265 industries covered by Zacks. In the last week, the industry has seen its average Zacks Rank improve, and it has gone from an average Zacks Rank of 2.96 to a rank of 2.75.
Best of the Group
There are several promising choices in this industry right now, such as Amphastar Pharmaceuticals (AMPH - Free Report) , Doctor Reddy’s (RDY - Free Report) , and Mylan NV , all of which are a Zacks Rank #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on RDY - FREE
Get the latest research report on AMPH - FREE